The patient is a 39+1 week gestation male, born to a 30-year-old gravida 2 para 2. Maternal prenatal labs were normal, and maternal medications included only a prenatal vitamin. The delivery was a non ...

Recombinant activated factor VII (Novoseven, Novo Nordisk Pharma A/S, Bagsvaerd, Denmark; rFVIIa) was initially developed for the treatment of hemophiliacs with inhibitors to factor VIII and IX.

A hematoma is similar to a bruise, but the damage that causes it occurs in larger blood vessels. It can lead to swelling, discoloration, and warmth, and may require medical treatment. While many ...